Your browser doesn't support javascript.
loading
Phase I trial of docetaxel plus lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 (177Lu-J591) for metastatic castration-resistant prostate cancer.
Batra, Jaspreet S; Niaz, Muhammad Junaid; Whang, Young E; Sheikh, Arif; Thomas, Charlene; Christos, Paul; Vallabhajosula, Shankar; Jhanwar, Yuliya S; Molina, Ana M; Nanus, David M; Osborne, Joseph R; Bander, Neil H; Tagawa, Scott T.
Afiliação
  • Batra JS; Department of Urology, Weill Cornell Medicine, New York, NY.
  • Niaz MJ; Department of Urology, Weill Cornell Medicine, New York, NY.
  • Whang YE; Department of Medicine, Division of Hematology/Oncology, University of North Carolina School of Medicine, Chapel Hill, NC.
  • Sheikh A; Department of Radiology, Icahn School of Medciine at Mount Sinai, New York, NY.
  • Thomas C; Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY.
  • Christos P; Department of Biostatistics and Epidemiology, Weill Cornell Medicine, New York, NY.
  • Vallabhajosula S; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY.
  • Jhanwar YS; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY.
  • Molina AM; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY.
  • Nanus DM; Department of Urology, Weill Cornell Medicine, New York, NY; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY.
  • Osborne JR; Division of Molecular Imaging and Therapeutics, Department of Radiology, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY.
  • Bander NH; Department of Urology, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY.
  • Tagawa ST; Department of Urology, Weill Cornell Medicine, New York, NY; Division of Hematology and Medical Oncology, Department of Medicine, Weill Cornell Medicine, New York, NY; Meyer Cancer Center, Weill Cornell Medicine, NewYork Presbyterian Hospital, New York, NY. Electronic address: stt2007@med.cornell.ed
Urol Oncol ; 38(11): 848.e9-848.e16, 2020 11.
Article em En | MEDLINE | ID: mdl-32600929
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Docetaxel / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias de Próstata Resistentes à Castração / Docetaxel / Anticorpos Monoclonais / Antineoplásicos Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article